Background Genome-wide association studies (GWAS) in Parkinson's disease have
increased the scope of biological knowledge about the disease over the past decade. We …

Common variant genome-wide association studies (GWASs) have, to date, identified> 24
risk loci for Parkinson's disease (PD). To discover additional loci, we carried out a GWAS …

Genome-wide association studies have identified a number of susceptibility loci in sporadic
Parkinson's disease (PD). Recent larger studies and meta-analyses have greatly expanded …

We performed the largest genome-wide association study of PD to date, involving the
analysis of 7.8 M SNPs in 37.7 K cases, 18.6 K UK Biobank proxy-cases, and 1.4 M controls …

We conducted a meta-analysis of Parkinson's disease genome-wide association studies
using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls. Twenty …

BACKGROUND: Genome-wide association studies (GWAS) for Parkinson's disease have
linked two loci (MAPT and SNCA) to risk of Parkinson's disease. We aimed to identify novel …

Although over 90 independent risk variants have been identified for Parkinson's disease
using genome-wide association studies, most studies have been performed in just one …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease
(PD) has led to the discovery of an increasing number of loci shown reliably to be associated …

Importance Large-scale genome-wide association studies in the European population have
identified 90 risk variants associated with Parkinson disease (PD); however, there are …

Background A genome-wide association study identified 13 single-nucleotide
polymorphisms (SNPs) significantly associated with Parkinson's disease. Small-scale …